Research library

Key finding

A systematic review of orthopaedic BPC-157 research found consistent improvements in tendon, ligament, muscle and bone-healing outcomes across the included preclinical studies.

Key finding

In rats with transected Achilles tendons, BPC-157 accelerated functional and structural healing and stimulated tendocyte growth in laboratory experiments.

Key finding

In full-thickness rat wounds, thymosin beta-4 increased re-epithelialization by up to 61%, collagen deposition and angiogenesis.

Key finding

This review links thymosin beta-4 to cell migration, angiogenesis, reduced inflammation and repair across multiple injury models.

Key finding

Early animal studies reported that BPC-157 protected gastric and duodenal tissue and produced anti-inflammatory effects across acute injury models.

Key finding

There is a current need for a therapy that can alleviate the social and economic burden that presents itself with debilitating and recurring musculoskeletal soft tissue injuries and disorders.

Key finding

Chemical burns take up a high proportion of burns admissions and can penetrate deep into tissues.

Key finding

This small study suggests that intra-articular injection of BPC-157 helps with multiple types of knee pain.

Key finding

UNLABELLED: BPC 157, a pentadecapeptide with extensive healing effects, has recently been suggested to contribute to angiogenesis.

Key finding

The study reports that this review highlights that given the robust preclinical evidence and high public interest, there is a critical need for well-designed human trials to assess the safety, efficacy, and clinical utility of BPC-157 in musculoskeletal medicine.

Key finding

The study reports that the present study reveals the progress regarding functions and applications of Tβ4.

Key finding

The objective of this double-blind, placebo-controlled, dose-escalation study is to evaluate safety, tolerability, and enhancement on healing of thymosin beta-4 (Tbeta-4) administered topically in patients with venous ulcers.

Key finding

This publication examines treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4.

Key finding

Thymosin beta 4 (T beta 4) is a 4.9 kDa polypeptide that interacts with G-actin and is thought to be an important mediator in cell proliferation, migration, and differentiation.

Key finding

These findings underscore the crucial role of rhTB4 in mitigating cardiac dysfunction in an ErbB2-dependent manner.

Key finding

BPC157 displays protective activity in various organs and tissues.

Key finding

Axonal and neuronal necrosis, demyelination, and cyst formation were counteracted.

Key finding

BPC 157 is a fundamental treatment that quickly restores blood supply to the ischemically injured area and rapidly activates collaterals.

Key finding

BPC 157, a pentadecapeptide derived from human gastric juice, has been demonstrated to promote the healing of different tissues, including skin, muscle, bone, ligament and tendon in many animal studies.

Key finding

Chronic nonhealing cutaneous wounds are a worldwide problem with no agent able to promote healing.